Category: Life Sciences
United States Life Sciences
-
Computer Aided Detection (CAD)
... 2030, growing at a CAGR of 9.1% over the analysis period 2024-2030. Mammography Modality, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$759.0 Million by the ... Read More
-
Blood Transfusion Diagnostics
... at a CAGR of 4.7% over the analysis period 2024-2030. Blood Transfusion Diagnostic Instruments, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.7 Billion by the ... Read More
-
Genotyping
... 15.3% over the analysis period 2024-2030. Polymerase Chain Reaction (PCR) Technology, one of the segments analyzed in the report, is expected to record a 15.9% CAGR and reach US$10.9 Billion by the end of the ... Read More
-
Herpes Marker Testing
... at a CAGR of 4.9% over the analysis period 2024-2030. Antibody / Antigen-Based Kits, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$332.9 Million by the ... Read More
-
Hepatitis B Vaccines
... at a CAGR of 4.4% over the analysis period 2024-2030. Combination Vaccines, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.6 Billion by the end of ... Read More
-
Clot Management Devices
... at a CAGR of 4.6% over the analysis period 2024-2030. Percutaneous Thrombectomy Devices, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.1 Billion by the end ... Read More
-
Flavored Syrups
... CAGR of 4.4% over the analysis period 2024-2030. Fruit Flavor, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$24.1 Billion by the end of the analysis ... Read More
-
Garden Tools
... CAGR of 4.9% over the analysis period 2024-2030. Pruning Tools, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$50.8 Billion by the end of the analysis ... Read More
-
Drug Screening
... CAGR of 16.7% over the analysis period 2024-2030. Drug Screening Products, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$16.7 Billion by the end of the ... Read More
-
Gaucher Disease Treatment
... at a CAGR of 3.8% over the analysis period 2024-2030. Enzyme Replacement Therapy, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$1.7 Billion by the end ... Read More
-
Surgical Sealants and Adhesives
... 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Natural Surgical Sealants and Adhesives, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$3.7 ... Read More
-
Library Furniture
... CAGR of 8.7% over the analysis period 2024-2030. Tables, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$3.9 Billion by the end of the analysis period. ... Read More
-
Long-Term Care
... CAGR of 5.5% over the analysis period 2024-2030. Public Payer, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.1 Trillion by the end of the analysis ... Read More
-
Microgrid as a Service (MaaS)
... Billion by 2030, growing at a CAGR of 15.7% over the analysis period 2024-2030. Grid Connected MaaS, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach US$4.2 ... Read More
-
Multi-Parameter Patient Monitoring Equipment
... 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Portable Device, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$12.8 Billion by the ... Read More
-
Whole Exome Sequencing
... at a CAGR of 20.2% over the analysis period 2024-2030. Whole Exome Sequencing Systems, one of the segments analyzed in the report, is expected to record a 21.3% CAGR and reach US$4.1 Billion by the ... Read More
-
Gluten Free Products
... at a CAGR of 5.9% over the analysis period 2024-2030. Gluten Free Bakery Products, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.7 Billion by the ... Read More
-
Endometrial Ablation Devices
... at a CAGR of 5.6% over the analysis period 2024-2030. Radiofrequency Ablation, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$628.5 Million by the end of ... Read More
-
Concierge Medicine Market in US 2025-2029
... the concierge medicine market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
U.S. Peripheral Vascular Angiography Contrast Media Market Size, Share & Trends Analysis Report By Modality (Ultrasound, Magnetic Resonance Imaging (MRI), CT/X-ray), By Product (Iodinated, Microbubble, Gadolinium-Based), By End Use, And Segment Forecasts, 2025 - 2030
... 2025 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of vascular diseases, particularly among the aging population and individuals with lifestyle-associated conditions such as diabetes, hypertension, and obesity, ... Read More
-
U.S. Pharmaceutical Market Size, Share & Trends Analysis Report By Molecule (Biologics & Biosimilars, Conventional Drugs), By Product, By Type, By Route Of Administration, By Disease, By Age Group, By Distribution Channel, And Segment Forecasts, 2025 - 2030
... an estimated value of USD 883.97 billion by 2030. This growth can be attributed to the rising prevalence of chronic diseases, increasing geriatric population, growing healthcare expenditure by government organizations, and extensive efforts to improve ... Read More
-
Cannabis in the US
... I to Schedule III, which could attract more investment and improve banking access for cannabis businesses. Euromonitor International's Cannabis in USA market report offers a comprehensive guide to the size and shape of this emerging ... Read More
-
Pharmaceutical Manufacturing
... US), as well as AstraZeneca and GlaxoSmithKline (both based in the UK), Bayer (Germany), Novartis and Roche (both based in Switzerland), and Sanofi (France). COMPETITIVE LANDSCAPE Pharmaceutical manufacturers compete to discover and commercialize ever-more effective ... Read More
-
Speech & Voice Recognition Software Developers in the US - Industry Market Research Report
... a digital format. Voice recognition can be used like a fingerprint and is aimed toward identifying the speaker, often for security purposes, using voice biometrics solutions. Voice recognition also helps consumers with high accuracy speech ... Read More
-
Nephrologists in the US - Industry Market Research Report
... size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares. Read More
Research Assistance
